Source: CLINICAL INFECTIOUS DISEASES. Unidade: FM
Subjects: LEISHMANIOSE CUTÂNEA, LEISHMANIA, ENSAIO CLÍNICO, BRASIL
ABNT
LYRA, Marcelo R et al. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil. CLINICAL INFECTIOUS DISEASES, v. 77, n. 4, p. 574-582, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57954. Acesso em: 21 out. 2024.APA
Lyra, M. R., Oliveira, L. F. A., Schubach, A. O., Sampaio, R. N. R., Rodrigues, B. C., Hueb, M., et al. (2023). A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil. CLINICAL INFECTIOUS DISEASES, 77( 4), 574-582. doi:10.1093/cid/ciad253NLM
Lyra MR, Oliveira LFA, Schubach AO, Sampaio RNR, Rodrigues BC, Hueb M, Cota G, Silva RE, Francesconi F, Amato VS. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil [Internet]. CLINICAL INFECTIOUS DISEASES. 2023 ; 77( 4): 574-582.[citado 2024 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57954Vancouver
Lyra MR, Oliveira LFA, Schubach AO, Sampaio RNR, Rodrigues BC, Hueb M, Cota G, Silva RE, Francesconi F, Amato VS. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil [Internet]. CLINICAL INFECTIOUS DISEASES. 2023 ; 77( 4): 574-582.[citado 2024 out. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57954